Literature DB >> 2850747

Anaesthesia and angiotensin-converting enzyme inhibitors. The effect of enalapril on peri-operative cardiovascular stability.

A P Yates1, D N Hunter.   

Abstract

The effect of enalapril pretreatment on the haemodynamic response to tracheal intubation and surgical stimulation has been studied in 22 patients. Enalapril 5 mg given 4 hours before operation was associated with a significant reduction in the pressor response associated with intubation (p less than 0.05) and surgical stimulation (p less than 0.005) compared with control. Heart rate changes were similar in the two groups. The role of the renin-angiotensin system in relation to the pressor response to sympathetic stimulation is discussed and it is concluded that angiotensin-converting enzyme inhibitors may help improve peri-operative cardiovascular stability.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850747     DOI: 10.1111/j.1365-2044.1988.tb05655.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  5 in total

1.  [Elevation of arterial pressure during surgery with a pneumatic tourniquet: an independent action of renin?].

Authors:  L Magnusson; M Rebagliati; E Buchser
Journal:  Can J Anaesth       Date:  1993-07       Impact factor: 5.063

Review 2.  Perioperative management of drug therapy, clinical considerations.

Authors:  M S Smith; H Muir; R Hall
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

Review 3.  Hypertension. Preoperative assessment and perioperative management.

Authors:  L Laslett
Journal:  West J Med       Date:  1995-03

4.  ARNI Pre-Operative Use and Vasoplegic Syndrome in Patients Undergoing Heart Transplantation or Left Ventricular Assist Device Surgery.

Authors:  Lamis Haider; Elisabeth Hugon-Vallet; Jean Philippe Constantin; Zakaria Riad; Laurent Sebbag; Nathan Mewton
Journal:  Med Sci (Basel)       Date:  2021-12-21

Review 5.  Perioperative hypertension management.

Authors:  Joseph Varon; Paul E Marik
Journal:  Vasc Health Risk Manag       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.